Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Medical Genetics · Glycogen Storage Disease Type IX

Symptoms, Diagnostic Testing & Look-Alikes

At a Glance

Glycogen Storage Disease Type IX (GSD IX) often presents with an enlarged liver, growth delays, and high ketone levels even when blood sugar is normal. Today, the condition is diagnosed using a simple genetic blood or saliva test, replacing the need for invasive liver biopsies.

Recognizing the signs of Glycogen Storage Disease Type IX (GSD IX) can be difficult because the symptoms often overlap with other common issues. Many parents first notice an unusually large or protruding belly or find that their child is exceptionally tired in the morning. Understanding these clinical markers is the first step toward getting the right support.

Common Symptoms of GSD IX

The symptoms of GSD IX can range from very mild to more significant, but several key features are frequently seen:

  • Hepatomegaly (Enlarged Liver): One of the most common signs [1][2]. Because the liver cannot release stored glycogen, the sugar builds up, causing the liver to swell. This may appear as a prominent abdomen [3].
  • Growth Delay: Some children with GSD IX may grow more slowly than their peers or have a shorter stature [4][5]. This happens because the body isn’t getting a steady supply of energy for growth.
  • Ketotic Normoglycemia: This is a unique “warning sign” in GSD IX. While many people think of low blood sugar (hypoglycemia) as the main issue, patients with GSD IX often produce high levels of ketones (an alternative fuel the body makes from fat) even when their blood sugar levels look normal [6]. This is called ketotic normoglycemia. It means the body is already “starving” for energy and burning fat, even before the blood sugar actually drops.
  • Elevated Liver Enzymes: Blood tests may show higher than normal levels of liver enzymes (transaminases), indicating the liver is under stress from the stored glycogen [1][2].

Warning Signs of a Metabolic Crisis

It is vital to recognize when the body’s energy stores have critically depleted. Extreme lethargy, uncharacteristic shaking, severe nausea, vomiting, or seizures are not just signs of being “hangry”—they are warning signs of severe hypoglycemia or dangerous ketosis and represent a medical emergency.

The Diagnostic Path: Why Genetics Come First

In the past, doctors often performed a liver biopsy—surgically removing a small piece of liver tissue—to diagnose GSD. Today, the medical community has shifted toward molecular genetic testing as the preferred method [7][8].

Genetic testing, such as Next-Generation Sequencing (NGS) panels or Whole Exome Sequencing (WES), is now the gold standard for several reasons [9][10]:

  1. Less Invasive: Requires a simple blood draw or saliva sample, avoiding the risks of surgery.
  2. Precise Subtyping: Identifies the exact gene (such as PHKA2 or PHKG2) causing the issue. Knowing the subtype helps predict the risk for future complications like liver scarring [11][12].
  3. Accuracy: Differentiates GSD IX from other similar conditions.

The “Look-Alikes”: GSD III and GSD VI

GSD IX belongs to a family of metabolic disorders, and its symptoms can look very similar to other types. Differentiating them is important because management and long-term risks vary.

  • GSD VI (Hers Disease): The closest “look-alike” to GSD IX. Both cause an enlarged liver and high ketones. They are so similar they are often only distinguishable through genetic testing [6][1].
  • GSD III (Cori or Forbes Disease): Also causes an enlarged liver and growth issues. However, GSD III frequently involves the muscles and the heart, whereas GSD IX (except for subtype IXd) typically focuses more on the liver [13][14]. A key difference is that patients with GSD III often have very high levels of creatine kinase (CK) in their blood, a marker of muscle involvement [15].

Because these conditions look so much alike, a precise genetic diagnosis ensures proper care. Once diagnosed, managing the condition day-to-day becomes the main priority. Learn more in Dietary Management & Daily Treatment Strategy.

Common questions in this guide

Why does my child have high ketones but normal blood sugar?
In GSD IX, the body struggles to access stored glycogen for energy. As a result, it begins burning fat instead, producing high levels of ketones even before blood sugar actually drops. This unique warning sign is known as ketotic normoglycemia.
How is Glycogen Storage Disease Type IX diagnosed today?
Doctors use molecular genetic testing, such as Next-Generation Sequencing (NGS) panels or Whole Exome Sequencing (WES). This simple blood or saliva test can identify the exact gene mutation and has replaced invasive liver biopsies as the gold standard for diagnosis.
What is the difference between GSD IX and GSD III?
While both conditions cause an enlarged liver and growth issues, GSD III frequently involves the muscles and the heart. Patients with GSD III often have very high levels of creatine kinase (CK) in their blood, whereas GSD IX typically focuses more on the liver.
What are the emergency warning signs of a metabolic crisis in GSD IX?
Extreme lethargy, uncharacteristic shaking, severe nausea, vomiting, or seizures are critical warning signs. These indicate that the body's energy stores are dangerously depleted, representing a metabolic crisis that requires emergency medical care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How do the ketone levels compare to blood sugar levels during a fast?
  2. 2.Was the diagnosis confirmed via a genetic panel (NGS) or whole exome sequencing (WES)?
  3. 3.How can we distinguish these symptoms from GSD III or VI based on current lab results (like CK levels or liver enzymes)?
  4. 4.How often should we be plotting height and weight to monitor for growth delays?
  5. 5.What specific physical warning signs indicate a metabolic crisis requiring emergency care?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Report of an Iranian child with chronic abdominal pain and constipation diagnosed as glycogen storage disease type IX: a case report.

    Zamanfar D, Hashemi-Soteh SM, Ghazaiean M, Keyhanian E

    Journal of medical case reports 2024; (18(1)):14 doi:10.1186/s13256-023-04295-0.

    PMID: 38212860
  2. 2

    Glycogen storage disease type IX: Long-term follow-up of 52 patients from three European countries.

    Magner M, Šáhó R, Slavíková P, et al.

    Molecular genetics and metabolism reports 2026; (46()):101297 doi:10.1016/j.ymgmr.2026.101297.

    PMID: 41732189
  3. 3

    Variability of clinical and biochemical phenotype in liver phosphorylase kinase deficiency with variants in the phosphorylase kinase (PHKG2) gene.

    Waheed N, Saeed A, Ijaz S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2020; (33(9)):1117-1123 doi:10.1515/jpem-2019-0603.

    PMID: 32697758
  4. 4

    Clinical and Molecular Variability in Patients with PHKA2 Variants and Liver Phosphorylase b Kinase Deficiency.

    Bali DS, Goldstein JL, Fredrickson K, et al.

    JIMD reports 2017; (37()):63-72 doi:10.1007/8904_2017_8.

    PMID: 28283841
  5. 5

    Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly.

    Quackenbush D, Devito J, Garibaldi L, Buryk M

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(4)):473-478 doi:10.1515/jpem-2017-0209.

    PMID: 29374762
  6. 6

    Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease.

    Hoogeveen IJ, van der Ende RM, van Spronsen FJ, et al.

    JIMD reports 2016; (28()):41-47 doi:10.1007/8904_2015_511.

    PMID: 26526422
  7. 7

    Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients.

    Sperb-Ludwig F, Pinheiro FC, Bettio Soares M, et al.

    Molecular genetics & genomic medicine 2019; (7(11)):e877 doi:10.1002/mgg3.877.

    PMID: 31508908
  8. 8

    PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutations.

    Choi R, Park HD, Kang B, et al.

    BMC medical genetics 2016; (17()):33 doi:10.1186/s12881-016-0295-1.

    PMID: 27103379
  9. 9

    Recent Advances in the Clinical Application of Next-Generation Sequencing.

    Ki CS

    Pediatric gastroenterology, hepatology & nutrition 2021; (24(1)):1-6 doi:10.5223/pghn.2021.24.1.1.

    PMID: 33505888
  10. 10

    Targeted exome sequencing identified a novel frameshift variant in the PGAM2 gene causing glycogen storage disease type X.

    Nayab A, Alam Q, Alzahrani OR, et al.

    European journal of medical genetics 2021; (64(9)):104283 doi:10.1016/j.ejmg.2021.104283.

    PMID: 34237446
  11. 11

    Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.

    Fernandes SA, Cooper GE, Gibson RA, Kishnani PS

    Molecular genetics and metabolism 2020; (131(3)):299-305 doi:10.1016/j.ymgme.2020.10.004.

    PMID: 33317799
  12. 12

    Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.

    Candela E, Montanari G, Zanaroli A, et al.

    Genes 2025; (16(5)) doi:10.3390/genes16050584.

    PMID: 40428406
  13. 13

    Liver transplantation in patients with type IIIa glycogen storage disease, cirrhosis and hepatocellular carcinoma.

    Iglesias Jorquera E, Tomás Pujante P, Ruiz García G, et al.

    Revista espanola de enfermedades digestivas 2019; (111(2)):168-169 doi:10.17235/reed.2018.5856/2018.

    PMID: 30318896
  14. 14

    A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme.

    Lim JA, Choi SJ, Gao F, et al.

    Molecular therapy. Methods & clinical development 2020; (18()):240-249 doi:10.1016/j.omtm.2020.05.034.

    PMID: 32637453
  15. 15

    Spectrum of AGL mutations in Chinese patients with glycogen storage disease type III: identification of 31 novel mutations.

    Lu C, Qiu Z, Sun M, et al.

    Journal of human genetics 2016; (61(7)):641-5 doi:10.1038/jhg.2016.24.

    PMID: 26984562

This page provides educational information about GSD IX symptoms and diagnostic testing. It is not a substitute for professional medical advice, and any suspected metabolic crisis requires immediate emergency care.

Get notified when new evidence is published on Glycogen storage disease due to phosphorylase kinase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.